RWJBarnabas Health - Robert Wood Johnson University Hospital

New Brunswick, New Jersey 08903

7 studies enrolling now · 12 studies all time

What they study most

Anal Cancer, Breast Cancer, Cardiac Toxicity, Cervical Cancer, Colon Cancer, Colorectal Cancer Screening, Diabetes Mellitus, Type 2, Ductal Breast Carcinoma In Situ, Early-stage Breast Cancer, Estrogen Receptor Positive, Gastric Cancer, HPV Positive Oropharyngeal Squamous Cell Carcinoma

Studies at this site

• KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer — Recruiting now
• E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers — Recruiting now
• E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers — Recruiting now
• ATATcH Alternating Treatment Plans for Advanced Cancer — Recruiting now
• Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer — Recruiting now
• Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted — Recruiting now
• Aim 3, Optimizing CRC Screening in Patients With Diabetes in Safety-net Primary Care Settings — Enrolling by invitation
• Adaptive Radiation Planning for the Reduction of Radiation-Induced Toxicity in Patients With Stage II-IV Non-small Cell Lung Cancer — Running, not enrolling
• Assessment of Early Radiation Oncology Involvement Alongside Standard Oncologic Care in the Managemet — Paused
• OCTANE: Adjuvant Liposomal Doxorubicin and Carboplatin for Early-stage Triple-negative Breast Cancer — Running, not enrolling
• Radiation Therapy in Treating Women With Early Stage Breast Cancer — Running, not enrolling
• Accelerated Partial Breast Radiation Therapy Using High-Dose Rate Brachytherapy in Treating Patients With Early Stage Breast Cancer After Surgery — Completed